medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2010, Number 3

<< Back Next >>

Rev Mex Patol Clin Med Lab 2010; 57 (3)

Histologic-microbiologic correlation in the diagnosis of Helicobacter pylori

Amores CJ, Arredondo BA, Martínez HB, Estrada NY, Pereira CL, Potente HA

Language: Spanish
References: 54
Page: 135-142
PDF size: 153.59 Kb.


ABSTRACT

Helicobacter pylori and its pathological potential has been the cause of multiple diseases of the stomach and duodenum. Its relationship with peptic ulcer disease has been the most studied one, but it has also been related with other illnesses. However, many of these associations even remain without a sure demonstration, and the debate for their confirmation even continues. The incidence of the Helicobacter pylori infection in the world is high existing a great number of reports; our country is not exempt of this, with a high percent of infection for this bacteria. Camagüey exhibits an alarming increment of patients affected by this cause, and for that reason was carried out a descriptive transverse observational study. From 107 patients that went to the Services of Endoscopy of the University Hospitals «Manuel Ascunce Domenech» and «Amalia Simoni» 17 completed the approaches for the study. The patients that had an age between 46 and 60 years constitute the most representative group, with a light prevalence of the male sex, the predominant endoscopic diagnosis was the chronic gastritis and the reflux esophagitis, followed by the duodenal ulcer and the duodenitis, the culture test was not effective in most of the cases. Although the endoscopic technique with the method of Violet Crystal stain is an invasive procedure its use is justified by its specificity for the quick diagnosis in the Helicobacter pylori infection, besides the economic advantages that it offers in regard to another stain methods.


REFERENCES

  1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.

  2. Marshall BJ et al. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439-444.

  3. Alexander GA, Brawley OW. Association of Helicobacter pylori infection with gastric cancer. Mil Med 2000; 165 (1): 21-27.

  4. Arredondo BA, Amores CJ. Historia, presente y pasado del Helicobacter pylori. Software educativo. Disponible en: http://www.finlay.cmw.sld.cu

  5. Mendoza RA, Cabalé BM, Fernández GME. Helicobacter Pylori y su relación con las lesiones gástricas. Hospital General «Lucía Iñiguez». Año 2001. Correo Científico Médico de Holguín 2003; 7 (2).

  6. Pounder RE, Ng D. The prevalence of H. pylori infection different countries. Aliment Pharmacol Therapy 1995; (2): 33-39.

  7. Disponible en: http: //es.wikipedia.org

  8. Davydov L, Cheng JW. The association of infection and coronary artery disease: An update. Expert Opin Investig Drugs 2000; 9 (11): 2505-2517

  9. Ercan I, Cakir BO, Uzel TS et al. The role of gastric Helicobacter pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck Surg 2006; 135 (1): 52-55.

  10. Katanga F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.

  11. Pounder RE, Ng D. The prevalence of H. pylori infection different countries. Aliment Pharmacol Therapy 1995; (2): 33-39.

  12. Linfoma tipo MALT de localización gástrica- infección por Helicobacter Pylori. Retos para el siglo XXI. Disponible en: www.helicobacterspain.es

  13. Morales JEL. Nociones de Estadística para Profesionales de la Salud. 2006. p. 184-194.

  14. De Boer WA, Tytgat GNJ. Regular new: Treatment of Helicobacter pylori infection. BMJ 2000; 320: 31-34.

  15. González-Carbajal PM. Aspectos epidemiológicos de mayor relieve de la infección por Helicobacter pylori. En: González-Carbajal M. Helicobacter pylori ¿El tercer dogma? Madrid: Autores Productores Asociados; 2003. p. 83-112.

  16. Macenlle GR, Gayoso DP, Sueiro BRA, Fernández SJ. Prevalencia de la infección por Helicobacter pylori en la población general adulta de la provincia de Ourense. Rev Esp Enferm Dig [serie en Internet]. 2006[cited 9 Nov 2009]; 98 (4): [aprox. 7p]. Avaidable from: http: //scielo.isciii.es.

  17. Zaterka S, Eisig JN, Chinzon D, Rothstein W. Factors related to Helicobacter pylori prevalence in an adult population in Brazil. Helicobacter 2007; 12: 82-8.

  18. Disponible en: http: //www.juventudtecnica.cu

  19. González-Carbajal PM, Rojas ZF, Grá OB, Ávalos GR. Prevalencia de la infección por Helicobacter pylori en pacientes dispépticos. Rev Panam Infectol 2004; 6 (4): 8-14.

  20. Luján LJL, Lopez CJA, Muñoz E. (1994) STS Studies in Span: A case study in STS transfer tecnoscience. 7/2: 14-16.

  21. Zubillaga M, Oliverti P, Calcagno ML, Coldman C, Caro R, Mitta A et al. Min 14C-UBT: A combination of gastric basal transit and 14C-Urea Breath Test for the detection of Helicobacter pylori infection in human beings. Nuclear Med Biol 1997; 24: 565-569.

  22. Martel C, Parsonnet J. Helicobacter pylori infection and gender: A meta-analysis of population-based prevalence surveys. Dig Dis Sci 2006; 51: 2292-301.

  23. Ahmed KS, Khan AA, Ahmed I. Prevalence study to elucidate the transmission pathways of Helicobacter pylori at oral and gastroduodenal sites of a South Indian population. Singapore Med J 2006; 47: 291-296.

  24. Koch A, Krause TG, Krogfelt K, Olsen OR, Fischer TK, Melbye M. Seroprevalence and risk factors for Helicobacter pylori infection in Greenlanders. Helicobacter 2005; 10: 433-442.

  25. Ndip RN, MacKay WG, Farthing MJ, Weaver LT. Culturing Helicobacter pylori from clinical specimens: Review of microbiologic methods. J Pediatr Gastroenterol Nutr 2003; 36: 616-622.

  26. Vakil N, Vaira D. Non-invasive tests for the diagnosis of infection. Rev Gastroenterol Disord 2004.4: 1-6.

  27. You WC, Brown LM, Zhang L et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974–983.

  28. Akhiani AA, Stensson A, Schon K, Lycke NY. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 2005; 174: 8144-8153.

  29. Sandler RS et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511.

  30. Robinson K, Loughlin MF, Potter R, Jenks PJ. Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. J Infect Dis 2005; 191: 579-587.

  31. Rieder G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 2005; 128: 1229–1242.

  32. Mendoza RA, Cabalé BM, Fernández GME. Helicobacter pylori y su relación con las lesiones gástricas. Hospital General «Lucía Iñiguez». Año 2001. Correo Científico Médico de Holguín 2003; 7 (2).

  33. Hernandez TM. Helicobacter pylori. La bacteria que más infecta al ser humano. Rev Cubana Aliment Nutr 2001; 15 (1): 42-54.

  34. Farreras R. Medicina Interna. (CD ROM) 14a ed. Cap 21. Citado Sep 2009. Madrid, España: Editorial Harcourt. 2000.

  35. Goldman: Cecil Medicine, (CD ROM) 23rd ed. Part XI. Chapter 141. Philadelphia, PA: WB Saunders; 2007.

  36. Deltenre M, Glupczynski Y, De Pérez C, Nyst JF, Burette A, Labbe M et al. The reliability of urease tests, histology and culture in the diagnosis of Campylobacter pylori infection. Scand J Gastroenterol 1989; 24 (suppl 160): 19-24.

  37. Tummala S et al. Update on the immunologic basis of Helicobacter pylori gastritis. Curr Opin Gastroenterol 2004; 20: 592-597.

  38. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 1996. 86: 200-205.

  39. Rauws EAJ. Helicobacter pylori 2. Diagnóstico. Curso de perfeccionamiento profesional. Aparato digestivo. Fundación Promedic-Promoción Médica; 1995; 11-13.

  40. Jemal A. Report Sees 7.6 Million Global 2007. Cancer Deaths. Reuters. Health information. Medscape. On line, april, 2008.

  41. Marshall BJ, Plankey MW, Hoffman SR, Boyd CL, Dye KR, Frierson NF et al. A 20-minute breath test for H. pylori. Am J Gastroenterol 1991; 86: 438-45.

  42. Martín de Argila C, Boixeda D y Gisbert JP. Diagnóstico de la infección por Helicobacter pylori. En: Boixeda D, Gisbert JP, Martín de Argila C (eds). Helicobacter pylori: ¿Dónde está el límite? Barcelona: Prous Science; 1996. p. 93-114.

  43. Makristathis A, Hirschl AM, Lehours P, Megraud F. Diagnosis of Helicobacter pylori infection. Helicobacter 2004; 9: 7-14.

  44. Glupczynski Y. Microbiological and serological diagnostic tests for Helicobacter pylori: An overwiew. Br Med Bull 1998; 54: 175-186.

  45. Ericson K, Nilbert M, Bladstrom A et al. Familial risk of tumors associated with hereditary nonpolyposis colorectal cancer: A Swedish population-based study. Scand J Gastroenterol 2004; 39: 1259-1265.

  46. Yuan Y and Hunt RH. Treatment of non-NSAID and non-H. pylori gastroduodenal ulcers and hypersecretory states. In: Wolfe MM et al (eds). Therapy of digestive disorders. 2nd ed. London, UK: Elsevier; 2006. p. 315-336.

  47. Hansen MJ, Pedersen OB y Bytzer P. Changing characteristics of patients with bleeding peptic ulcer. DDW 2002, T1544.

  48. Lujan LJL, Lopez CJA, Muñoz E. (1994): STS Studies in Span: A case study in STS transfer tecnoscience. 7/2: 14-16.

  49. Ogura K, Hirata Y, Yanai A et al. The effect of Helicobacter pylori eradication on incidence of gastric cancer. Gastroenterology 2006; 130 (4 suppl 2): A183.

  50. Versalovic J, Fox JG. Helicobacter. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. 8th ed. Washington: ASM Press; 2003. p. 915-928.

  51. Ndip RN, MacKay WG, Farthing MJ, Weaver LT. Culturing Helicobacter pylori from clinical specimens: Review of microbiologic methods. J Pediatr Gastroenterol Nutr 2003; 36: 616-622.

  52. Domínguez MJE, Leodolter A, Sauerbruch T, Malfertheiner P. A citric acid solution is an optimal test drink in the 13C-urea breath test for diagnosis of H. pylori infection. Gut 1997; 40: 459-462.

  53. Boccio J, Zubillaga M. Helicobacter pylori. Conceptos actuales. Editorial. APPTLA 1997; 47: 194-196.

  54. Zubillaga M, Oliverti P, Calcagno ML, Coldman C, Caro R, Mitta A et al. Min 14C-UBT: A combination of gastric basal transit and 14C-Urea Breath Test for the detection of Helicobacter pylori infection in human beings. Nuclear Med Biol 1997; 24: 565-569.




2020     |     www.medigraphic.com